Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy

Table 2 IC₅₀ values in control and ACE2 knockdown 468/EPR cells

Cell	IC₅₀	95% CI (profile likelihood)	P-value
468/EPR shControl	11.53	10.89 to 12.21
468/EPR shACE2 #1	0.47	0.3717 to 0.5565	0.0316
468/EPR shACE2 #2	0.94	0.8993 to 0.9837	0.0347
468/EPR shACE2 #3	0.68	0.2337 to 1.085	0.0345

ISSN: 1479-5876